TNFRSF10B and cancer: Apo2L/TRAIL induces apoptosis in cancer cells through interactions with death receptor 4 (DR4) and DR5, which form the death-inducing signal complex (DISC) by binding to FADD and caspase-8 or caspase-10 [17]–[19].